EBS:NYE-Emergent Biosolutions Inc (USD)

COMMON STOCK | Drug Manufacturers - Specialty & Generic |

Last Closing

USD 9.36

Change

-0.05 (-0.53)%

Market Cap

N/A

Volume

1.11M

Analyst Target

USD 112.29
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-01-14 )

Largest Industry Peers for Drug Manufacturers - Specialty & Generic

Symbol Name Price(Change) Market Cap
ZTS Zoetis Inc

-1.91 (-1.15%)

USD 74.37B
HLN Haleon plc

-0.09 (-0.99%)

USD 42.79B
TAK Takeda Pharmaceutical Co Ltd A..

+0.05 (+0.38%)

USD 41.33B
RDY Dr. Reddy’s Laboratories Ltd..

-0.05 (-0.33%)

USD 13.11B
CTLT Catalent Inc

N/A

USD 11.52B
ELAN Elanco Animal Health

N/A

USD 5.65B
AMRX Amneal Pharmaceuticals, Inc. C..

+0.13 (+1.68%)

USD 3.68B
BHC Bausch Health Companies Inc

+0.08 (+1.08%)

USD 2.91B
CPHI China Pharma Holdings Inc

N/A

USD 3.69M
YCBD cbdMD Inc

+0.03 (+6.15%)

USD 1.96M

ETFs Containing EBS

XB4A:F Xtrackers ATX UCITS ETF 1.. 19.72 % 0.00 %

+0.40 (+0.22%)

USD 0.04B
BNKE:LSE Lyxor EURO STOXX Banks UC.. 3.04 % 0.00 %

+3.17 (+0.22%)

USD 0.30M
C005:XETRA Amundi Index Solutions - .. 2.32 % 0.00 %

-0.30 (0.22%)

USD 0.13B
BINV 2023 ETF Series Trust - B.. 2.15 % 0.00 %

+0.06 (+0.22%)

USD 0.14B
EMUM:SW iShares MSCI EMU Mid Cap .. 1.93 % 0.00 %

+0.32 (+0.22%)

USD 0.14B
LDEG:LSE L&G Quality Equity Divide.. 1.30 % 0.00 %

+9.20 (+0.22%)

N/A
LDEU:LSE L&G Quality Equity Divide.. 1.30 % 0.00 %

+0.06 (+0.22%)

USD 0.04B
EL43:XETRA Deka MSCI Europe MC UCITS.. 1.18 % 0.00 %

-0.06 (0.22%)

USD 0.02B
FEP First Trust Europe AlphaD.. 0.00 % 0.80 %

+0.24 (+0.22%)

USD 0.18B
FEUZ First Trust Eurozone Alph.. 0.00 % 0.80 %

+0.35 (+0.22%)

USD 0.02B
EUMD:LSE iShares MSCI Europe Mid C.. 0.00 % 0.00 %

-0.01 (0.22%)

USD 0.27B
FEUZ:LSE First Trust Eurozone Alph.. 0.00 % 0.00 %

+41.50 (+0.22%)

USD 0.06B
FEUD:LSE First Trust Eurozone Alph.. 0.00 % 0.00 %

+38.50 (+0.22%)

USD 0.01B
IS3H:F iShares IV Public Limited.. 0.00 % 0.00 %

-0.01 (0.22%)

N/A
IS3H:XETRA iShares MSCI EMU Mid Cap .. 0.00 % 0.00 %

+0.15 (+0.22%)

USD 0.13B
FTEU:LSE First Trust Eurozone Alph.. 0.00 % 0.00 %

+0.66 (+0.22%)

USD 0.06B
FTGE:XETRA First Trust Eurozone Alph.. 0.00 % 0.00 %

+0.30 (+0.22%)

USD 0.08B

Market Performance

  Market Performance vs. Industry/Classification (Drug Manufacturers - Specialty & Generic) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -2.09% 64% D 23% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -2.09% 64% D 22% F
Trailing 12 Months  
Capital Gain 361.08% 100% F 100% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 361.08% 100% F 100% F
Trailing 5 Years  
Capital Gain -83.30% 21% F 3% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -83.30% 21% F 3% F
Average Annual (5 Year Horizon)  
Capital Gain -18.24% 7% C- 3% F
Dividend Return -18.24% 7% C- 3% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 101.93% 20% F 8% B-
Risk Adjusted Return -17.90% 20% F 12% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector